Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding status notice on the Study Details page for NCT03684694 has been removed; core trial information remains unchanged.SummaryDifference0.3%

- Check43 days agoChange DetectedResults data are now visible on the Study Details page, with the Results First Posted date listed as 2024-02-06, alongside outcome measures. This marks a shift from purely protocol content to published study results.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdated to v3.2.0 with a new clinical term added and a government-operating-status notice; older version note v3.1.0 removed.SummaryDifference2%

- Check79 days agoChange DetectedPage version updated to v3.1.0 and 'Diffuse large b-cell lymphoma' removed from the content; core page content likely updated without introducing new topics.SummaryDifference0.1%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.